We break down our two favorite option trades in the market currently using Fibonacci analysis. Biotech is leading the charge lower, while this precious metal could be about to lift off.
Recent Posts
- Engineering the Markets: Precision Patterns and Profitability – March 26th
- Engineering the Markets: Precision, Patterns, and Profitability – March 19th
- Todd Gordon: Market Recovery Takes Shape as ‘Mag Seven’ Deliver Strong Earnings
- Mapping Global Trade Barriers: The OTRI Report
- Engineering the Markets: Precision, Patterns, and Profitability – March 12th
Recent Comments
- Nick R on Nvidia Earnings: Will NVDA Keep Soaring or Stumble?: “Hey Nigel, thanks for your feedback! Just to clarify, our voiceovers are not AI-generated. They’re recorded by our team member,…” Mar 14, 09:18
- Nigel on Nvidia Earnings: Will NVDA Keep Soaring or Stumble?: “Definitely NOT a fan of the AI generated voiceover you’ve been publishing lately. Please! bring back the personalized Todd…” Feb 25, 21:32
- ed on Is the Market Overbought? Key Market Indicators You Need to Know Now: “Tod, Spikes, up and down, due to volatility always take me, and my account…, by surprise, so…” Feb 22, 15:21
- Karl Skrifvars on Is the Market Overbought? Key Market Indicators You Need to Know Now: “do away with the text at the bottom of the videos” Jan 13, 09:07